RuiPeng Pet Healthcare Secures RMB 246 Million Strategic Investment from Sunshine Ronghui to Advance Pet Insurance and Industry Integration

VCBeat News: On November 17, Ruipeng Pet Healthcare Group announced that it had secured RMB 246 million in strategic investment from Sunshine Fusion Capital.

It was revealed that the funds will be used for store expansion and subsequent operations, store maintenance and upgrades, and the operation of Ruipeng University.

The partnership with Sunshine Ronghui Capital is also seen as a sign that Ruipeng Pet will make significant inroads into the pet insurance sector.

New Ruipeng Group Co., Ltd. is one of the largest chains in terms of the number of veterinary hospitals and remains the only publicly listed pet healthcare company. Established in November 1998, it was listed on the National Equities Exchange and Quotations (NEEQ) in August 2016. Its core business focuses on veterinary medical care and health management, complemented by pet grooming services, while also retailing pet food and supplies.

As of now, Ruipeng Pet operates and holds equity stakes in more than 200 referral centers, central hospitals, specialized hospitals, and community clinics across China, with a presence in over 20 core cities including Shanghai, Guangzhou, Shenzhen, Changsha, and Beijing.

Benefiting from the continuous increase in the number of stores and group-level management ensuring operational efficiency, Ruipeng Pet Healthcare has maintained rapid revenue growth since its listing. The 2017 semi-annual report showed that the company achieved a revenue of RMB 127 million in the first half of the year, a year-on-year increase of 51.24%, with an annual consultation volume exceeding 800,000 cases.

As the first publicly listed company in the pet healthcare sector, Ruipeng Pet has rarely accepted external investment. Public records indicate that Fortune Capital (Fuchen Venture Capital) previously made two investments in Ruipeng Pet, one in 2015 and another in the first half of this year.

Pet insurance in China remains in its exploratory phase, yet it is regarded as the next value-added growth point for the pet industry. Once breakthroughs are achieved on the payment front, the demand growth in the pet healthcare consumer market will be further amplified.

Sunshine Ronghui Capital is one of the first insurance private equity fund managers approved by the China Insurance Regulatory Commission (CIRC). With assets under management totaling RMB 16 billion, the firm has actively invested in sectors such as healthcare and emerging consumption. It has invested in approximately 40 outstanding companies, including Qihoo 360, JD Finance, Didi Chuxing, Bikang Pharmaceutical, and Mindray Medical.

Leveraging Sunshine Insurance’s insurance capital background, Ruipeng Pet Healthcare Group will collaborate with Sunshine Ronghui Capital’s strategic insurance resources following this round of financing. The two parties will deepen cooperation in areas such as pet insurance and consumer finance services, accelerate nationwide network expansion across China, and speed up industry consolidation.

Huang Shengxuan, Managing Director at Sunshine Ronghui Capital, stated, “The pet healthcare industry is currently in a phase of rapid development, and the fragmented market landscape presents significant opportunities for consolidation. We have strong confidence in Ruipeng’s extensive operational expertise and high level of professional medical care. We look forward to deepening our collaboration with Ruipeng in areas such as industry consolidation, pet insurance, and consumer financial services, thereby contributing to the growth of the sector.”